Literature DB >> 15501140

CNS injury: the role of the cytokine IL-1.

Rosemary M Gibson1, Nancy J Rothwell, Ros A Le Feuvre.   

Abstract

Injury to the central nervous system (CNS) and the resulting neuronal loss contribute significantly to morbidity and mortality in human and domestic animal populations. Most insults induce inflammation and the expression of cytokines. The specific roles of these proteins in neurological damage and repair are not completely understood. However, members of the interleukin-1 (IL-1) family have clear therapeutic potential: the IL-1 agonists, IL-1 alpha and IL-1 beta, are induced by CNS injury, and central injection of IL-1 increases, whilst peripheral or central administration of the IL-1 antagonist, IL-1ra, reduces the extent of the damage by more than 50%. The mechanism of action of these cytokines is the subject of intense research. In this review, we summarise approaches that are being used to investigate neuronal cell death, and the contribution of inflammation and cytokines, in particular the IL-1 family, to neurodegenerative disorders.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15501140     DOI: 10.1016/j.tvjl.2003.10.016

Source DB:  PubMed          Journal:  Vet J        ISSN: 1090-0233            Impact factor:   2.688


  29 in total

Review 1.  Humoral sleep regulation; interleukin-1 and tumor necrosis factor.

Authors:  Kathryn A Jewett; James M Krueger
Journal:  Vitam Horm       Date:  2012       Impact factor: 3.421

2.  HIV-1-infected and/or immune activated macrophages regulate astrocyte SDF-1 production through IL-1beta.

Authors:  Hui Peng; Nathan Erdmann; Nicholas Whitney; Huangyu Dou; Santhi Gorantla; Howard E Gendelman; Anuja Ghorpade; Jialin Zheng
Journal:  Glia       Date:  2006-11-01       Impact factor: 7.452

Review 3.  Without nerves, immunology remains incomplete -in vivo veritas.

Authors:  Andrew J Shepherd; James E G Downing; Jaleel A Miyan
Journal:  Immunology       Date:  2005-10       Impact factor: 7.397

Review 4.  Neuroinflammation and synaptic loss.

Authors:  Jagadeesh S Rao; Matthew Kellom; Hyung-Wook Kim; Stanley I Rapoport; Edmund A Reese
Journal:  Neurochem Res       Date:  2012-02-07       Impact factor: 3.996

5.  Reducing effect of IL-32α in the development of stroke through blocking of NF-κB, but enhancement of STAT3 pathways.

Authors:  Chul Ju Hwang; Hyung-Mun Yun; Yu Yeon Jung; Dong Hun Lee; Na Young Yoon; Hyun Ok Seo; Jin-Yi Han; Ki-Wan Oh; Dong Young Choi; Sang-Bae Han; Do Young Yoon; Jin Tae Hong
Journal:  Mol Neurobiol       Date:  2014-05-24       Impact factor: 5.590

6.  Binding of NIR-conPK and NIR-6T to astrocytomas and microglial cells: evidence for a protein related to TSPO.

Authors:  Michelle Sexton; Grace Woodruff; Eiron Cudaback; Faith R Kreitzer; Cong Xu; Yi Hsing Lin; Thomas Möller; Mingfeng Bai; H Charles Manning; Darryl Bornhop; Nephi Stella
Journal:  PLoS One       Date:  2009-12-18       Impact factor: 3.240

7.  Impaired response to amphetamine and neuronal degeneration in the nucleus accumbens of autoimmune MRL-lpr mice.

Authors:  Kelly K Anderson; David A Ballok; Neena Prasad; Henry Szechtman; Boris Sakic
Journal:  Behav Brain Res       Date:  2005-09-23       Impact factor: 3.332

8.  DIDS protects against neuronal injury by blocking Toll-like receptor 2 activated-mechanisms.

Authors:  Hang Yao; Hady Felfly; Juan Wang; Dan Zhou; Gabriel G Haddad
Journal:  J Neurochem       Date:  2008-12-10       Impact factor: 5.372

9.  Human umbilical cord blood cells decrease microglial survival in vitro.

Authors:  Lixian Jiang; Tracy Womble; Samuel Saporta; Ning Chen; Cyndy Davis Sanberg; Paul R Sanberg; Alison E Willing
Journal:  Stem Cells Dev       Date:  2010-02       Impact factor: 3.272

10.  Simvastatin attenuates microglial cells and astrocyte activation and decreases interleukin-1beta level after traumatic brain injury.

Authors:  Bo Li; Asim Mahmood; Dunyue Lu; Hongtao Wu; Ye Xiong; Changsheng Qu; Michael Chopp
Journal:  Neurosurgery       Date:  2009-07       Impact factor: 4.654

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.